Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report
- PMID: 39298692
- DOI: 10.1200/PO.24.00228
Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report
Abstract
Imatinib may be a useful targeted agent for patients with advanced gastric adenocarcinoma who have KIT mutations.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
